• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia Subscriptions
    • Books
    • eBooks
    • ABPN SA Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Home » Autism: The Goal Posts Have Moved

Autism: The Goal Posts Have Moved

June 10, 2020
Peter Smith, PsyD.
From The Carlat Psychiatry Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue
Peter Smith, PsyD. Dr. Smith has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Review of: Rødgaard EM et al, JAMA Psychiatry 2019;76(11):1124–1132

Study Type: Meta-analysis of meta-analyses

We’ve heard a lot about the increasing prevalence of autism, up from 1 in 2,000 in 1965 to 1 in 45 in 2015. What we have not heard are definitive answers as to why. This study used a novel design to explore whether the research has included an increasing number of mild cases along the autism spectrum in recent decades.

The authors examined differences between subjects identified with autism vs healthy controls across neurocognitive measures. The magnitude of the difference was measured by effect size, and they assessed how those effect sizes changed in studies dating back to the 1980s. For comparison, the authors conducted the same analysis in studies of schizophrenia, a condition whose prevalence (1%) has not changed over time. The autism data were based on 11 meta-analyses involving 27,723 subjects and 7 neurocognitive constructs. For schizophrenia, they used 4 meta-analyses involving 10,159 subjects and 3 neurocognitive constructs.

For the autism group, the differences between the controls and those diagnosed with autism shrank over time in all 7 neurocognitive constructs. Those differences reached statistical significance for 5 of those constructs: emotion recognition, theory of mind, executive planning, the event-related potential P3b on EEG, and brain size. Between 2000 and 2015, the effect sizes for these 5 measures decreased by 45%–80%. In contrast, no changes in effect sizes were found when comparing neurocognitive constructs related to schizophrenia.

The changes in the autism studies correlated with the year of the study and were not explained by changes in study design or by inclusion of high-functioning autism in the samples. Although DSM-5 introduced new criteria for autism, most of the changes observed in this study occurred during the DSM-IV era (1994–2013).

TCPR’s Take
It looks like our concept of autism has broadened in the past 20 years. Rates of diagnosis are on the rise, and research studies are including people with autism who look increasingly like healthy controls. When a patient presents with this diagnosis, look carefully at how it was made. Milder cases will likely benefit from a non-pathologizing approach that emphasizes their strengths and weaknesses.

podcastsTo learn more, listen to our 7/27/20 podcast, “How to Talk to Patients With Autism.” Search for “Carlat” on your podcast store.
General Psychiatry
KEYWORDS autism autism-spectrum-disorder-autism-spectrum-disorder diagnosis research-update
Peter Smith, PsyD.

How to Switch Antipsychotics

More from this author
www.thecarlatreport.com
Issue Date: June 10, 2020
SUBSCRIBE NOW
Table Of Contents
CME Post-Test - Borderline Personality Disorder, TCPR, June-July 2020
Locked-In Syndrome and Quality of Life
Brief Coverage of Psychiatric News
Take a Breather: A Mindful Tactic for Borderline Dysphoria
A Pragmatic Approach to Borderline Personality Disorder
The Modafinils in Bipolar Depression
When Further Medication Trials Seem Futile
Autism: The Goal Posts Have Moved
DOWNLOAD NOW
Featured Book
  • MFB6eCover.jpg

    Medication Fact Book for Psychiatric Practice, Sixth Edition (2022)

    Guidance, clinical pearls, and bottom-line assessments covering the medications you use in your...
    READ MORE
Featured Video
  • therapist_canstockphoto9201097.jpg
    General Psychiatry

    Using SAMe In Clinical Practice with Garrett Rossi, MD

    Read More
Featured Podcast
  • canstockphoto11543850.jpg
    General Psychiatry

    Elvis, Adderall, and a Broken Heart - Part 1

    A new medical investigation changes our understanding of Elvis Presley’s untimely death and offer some pearls for modern psychiatric practice.

    Listen now
Recommended
  • Approaches to Autism Intervention

    January 31, 2022
    canstockphoto2240982_child-bubbles_thumb.jpg
  • Currently Available Cannabis Products

    September 1, 2022
  • Interpreting Assessment Discrepancies from Multiple Sources

    October 17, 2022
    ChildAssessment.png
  • Approaches to Autism Intervention

    January 31, 2022
    canstockphoto2240982_child-bubbles_thumb.jpg
  • Currently Available Cannabis Products

    September 1, 2022
  • Interpreting Assessment Discrepancies from Multiple Sources

    October 17, 2022
    ChildAssessment.png
  • Approaches to Autism Intervention

    January 31, 2022
    canstockphoto2240982_child-bubbles_thumb.jpg
  • Currently Available Cannabis Products

    September 1, 2022
  • Interpreting Assessment Discrepancies from Multiple Sources

    October 17, 2022
    ChildAssessment.png

About

  • About Us
  • CME Center
  • FAQ
  • Contact Us

Shop Online

  • Newsletters
  • Multimedia Subscriptions
  • Books
  • eBooks
  • ABPN Self-Assessment Courses

Newsletters

  • The Carlat Psychiatry Report
  • The Carlat Child Psychiatry Report
  • The Carlat Addiction Treatment Report
  • The Carlat Hospital Psychiatry Report
  • The Carlat Geriatric Psychiatry Report

Contact

info@thecarlatreport.com

866-348-9279

PO Box 626, Newburyport MA 01950

Follow Us

Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

© 2023 Carlat Publishing, LLC and Affiliates, All Rights Reserved.